KXRG has significant effects on both local and systemic inflammatory responses, at least in part through selectively targeting COX-2 and IL-6; it prevents LPS-induced tissue damage in the small intestine, liver, and kidneys, and reduces memory impairments and neuroinflammatory responses. This evidence concerns the gene PTGS2 and memory impairment.